Aegean Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aegean Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aegean Study Today - Breaking & Trending Today

AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC

Published: May 19, 2023

Expert oncologist John Heymach, MD, PhD, reviews data from the phase 3 AEGEAN trial following updates presented at the 2023 AACR annual meeting.

Source: onclive.com

Related Topics:

Neoadjuvant DurvalumabJohn HeymachAdjuvant DurvalumabPartnership WithNon Small Cell Lung CancerEarly Stage Lung CancerEarly Stage NsclcDurvalumab TherapyOverall SurvivalProgression Free SurvivalEvent Free SurvivalPathologic Complete ResponsePd L1 ExpressionPd L1 LevelAdverse EventsDrug Adverse EventAegean StudyAegean TrialEfs BicrDfs Bicr

Resectable Non–Small Cell Lung Cancer: Neoadjuvant Treatment Strategies

Published: April 28, 2023

Focused discussion on the selection of neoadjuvant therapy in patients with resectable NSCLC in light of recent clinical trials.

Source: onclive.com

Related Topics:

Recent UpdatesTranslating EvidenceClinical PracticeSmall Cell Lung CancerNeoadjuvant Treatment StrategiesLung CancerNon Small Cell Lung CancerTrio TherapyImmune Checkpoint InhibitorsNeoadjuvant TherapyPerioperative TherapyNeoadjuvant ChemotherapyCheckmate 816Nivolumab TherapyNeoadjuvant NivolumabMolecular TestingGenetic TestingMutational AnalysisPdl1 StatusPdl1 ExpressionNadim IiNadim 2Pathologic Complete ResponsePath CrAegean Study